Interleukin-6/interleukin-10 ratio and immune dysregulation after radiofrequency ablation

The IL-6/IL-10 ratio may constitute a clinically relevant biomarker indicative of immune dysregulation after RFA, with potential implications for understanding inflammation-driven outcomes and tailoring post-RFA management.

Authors

Institutions

Publication Details

Journal
World Journal of Hepatology
Published
2026-01-27
DOI
https://doi.org/10.4254/wjh.v18.i1.113429
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Interleukin-6/interleukin-10 ratio and immune dysregulation after radiofrequency ablation

Lei Pang, Bo-Lin Wu, Wen Cheng, Di Tang et al.
World Journal of Hepatology
Hepatocellular Carcinoma Treatment and Prognosis
article

Interleukin-6/interleukin-10 ratio and immune dysregulation after radiofrequency ablation

Lei Pang, Bo-Lin Wu, Wen Cheng, Di Tang, Xin Bai, Wan-Lin Zhou, Hui-Jia Zhao
article en

Abstract

The IL-6/IL-10 ratio may constitute a clinically relevant biomarker indicative of immune dysregulation after RFA, with potential implications for understanding inflammation-driven outcomes and tailoring post-RFA management.

World Journal of HepatologyVol. 18(1)
Harbin Medical University (CN), Third Affiliated Hospital of Harbin Medical University (CN)
Good health and well-being
Openalex Percentile: Top 76%
Hepatocellular Carcinoma Treatment and Prognosis
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.